CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Unexpected Hepatitis B Virus Infection After Liver Transplantation — U.S. 2014–2019
-
Jul 09 2021
-
-
Source: MMWR Morbidity Mortal Weekly Rep. 70(27):961-966
[PDF-291.10 KB]
Details:
-
Journal Article:Morbidity and Mortality Weekly Report (MMWR)
-
Personal Author:
-
Description:Unexpected donor-derived hepatitis B Virus (HBV) infection is defined as a new HBV infection in a recipient of a transplanted organ from a donor who tested negative for total antihepatitis B core antibody (total anti-HBc), hepatitis B surface antigen (HBsAg), and HBV DNA* before organ procurement. Such infections are rare and are associated with injection drug use among deceased donors (1). During 2014-2019, CDC received 20 reports of HBV infection among recipients of livers from donors who had no evidence of past or current HBV infection. Investigation included review of laboratory data and medical records. Fourteen of these new HBV infections were detected during 2019 alone; infections were detected a median of 38 (range = 5-116) weeks after transplantation. Of the 14 donors, 13 were hepatitis C Virus (HCV)-seropositive| and had a History of injection drug use within the year preceding death, a positive toxicology result, or both. Because injection drug use is the most commonly reported risk factor for hepatitis C,| providers caring for recipients of organs from donors who are HCV-seropositive or recently injected drugs should maintain awareness of infectious Complications of injection drug use and monitor recipients accordingly (2). In addition to tTesting for HBV DNA at 4-6 weeks after transplantation, clinicians caring for liver transplant recipients should consider tTesting for HBV DNA 1 year after transplantation or at any time if signs and symptoms of viral hepatitis develop, even if previous tests were negative (2).
-
Subjects:
-
Source:
-
Series:
-
ISSN:0149-2195 (print);1545-861X (digital);
-
Pubmed ID:34237046
-
Pubmed Central ID:PMC8312757
-
Document Type:
-
Place as Subject:
-
Pages in Document:6 pdf pages
-
Volume:70
-
Issue:27
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
